We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals

60 hedge funds and large institutions have $33.9M invested in Cumberland Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

88% less call options, than puts

Call options by funds: $1K | Put options by funds: $8K

Holders
60
Holders Change
+60
Holders Change %
% of All Funds
1.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
60
Increased
Reduced
Closed
Calls
$1K
Puts
$8K
Net Calls
-$7K
Net Calls Change
-$7K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
AI
1
Ariel Investments
Illinois
$7.29M +$7.09M +1,425,705 New
BIT
2
BlackRock Institutional Trust
California
$4.99M +$4.86M +976,350 New
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$3.77M +$3.67M +737,694 New
KIM
4
Kestrel Investment Management
California
$3.21M +$3.13M +628,939 New
UCFA
5
United Capital Financial Advisors
Texas
$2.25M +$2.19M +439,364 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.37M +$1.33M +267,832 New
Renaissance Technologies
7
Renaissance Technologies
New York
$1.28M +$1.25M +250,868 New
Morgan Stanley
8
Morgan Stanley
New York
$1.27M +$1.24M +248,531 New
Northern Trust
9
Northern Trust
Illinois
$592K +$577K +115,997 New
LSV Asset Management
10
LSV Asset Management
Illinois
$512K +$499K +100,200 New
BA
11
BlackRock Advisors
Delaware
$497K +$484K +97,241 New
Invesco
12
Invesco
Georgia
$481K +$468K +94,150 New
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$479K +$467K +93,800 New
BA
14
Bard Associates
Illinois
$474K +$462K +92,840 New
HighTower Advisors
15
HighTower Advisors
Illinois
$386K +$376K +75,577 New
Deutsche Bank
16
Deutsche Bank
Germany
$375K +$367K +73,812 New
MC
17
Menta Capital
California
$318K +$310K +62,206 New
Goldman Sachs
18
Goldman Sachs
New York
$316K +$308K +61,889 New
GCP
19
GSA Capital Partners
United Kingdom
$288K +$280K +56,295 New
PP
20
Paloma Partners
Connecticut
$245K +$239K +47,979 New
RJA
21
Raymond James & Associates
Florida
$242K +$236K +47,366 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$218K +$212K +42,618 New
SKK
23
Shepherd Kaplan Krochuk
Massachusetts
$212K +$206K +41,500 New
Citadel Advisors
24
Citadel Advisors
Florida
$199K +$194K +38,959 New
SIM
25
Spark Investment Management
New York
$196K +$193K +38,700 New

CPIX Hedge Fund Activity: Q2 2013 in Review

60 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2013, worth a combined $33.9M.

Buyers outnumbered sellers: 60 funds opened new CPIX positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

  • 60 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $33.9M of Cumberland Pharmaceuticals stock for Q2 2013.
  • 60 funds opened new Cumberland Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +60 holders.

Based on aggregated 13F filings for Q2 2013.